| Authors: |
Gijzen L; Model Development, MIMETAS BV, De Limes 7, Oegstgeest, 2342DH, NETHERLANDS., Bokkers M; Model Development, MIMETAS BV, De Limes 7, Oegstgeest, 2342DH, NETHERLANDS., Hanamsagar R; Sanofi Research and Development Center Cambridge, 350 Water Street, Cambridge, Massachusetts, 02141, UNITED STATES., Olivier T; Model Development, MIMETAS BV, De Limes 7, Oegstgeest, 2342DH, NETHERLANDS., Burton T; Model Development, MIMETAS BV, De Limes 7, Oegstgeest, South Holland, 2342DH, NETHERLANDS., Tool LM; Model Development, MIMETAS BV, De Limes 7, Oegstgeest, 2342DH, NETHERLANDS., Rahman MF; Sanofi Research and Development Center Cambridge, 350 Water Street, Cambridge, Massachusetts, 02141, UNITED STATES., Lowman J; Model Development, MIMETAS BV, De Limes 7, Oegstgeest, 2342DH, NETHERLANDS., Savova V; Sanofi Research and Development Center Cambridge, 350 Water Street, Cambridge, Massachusetts, 02141, UNITED STATES., Means TK; Autoimmunity Cluster, Immunology & Inflammation Research Therapeutic Area, Sanofi Research and Development Center Cambridge, 350 Water Street, Cambridge, Massachusetts, 02141, UNITED STATES., Lanz HL; Model Development, MIMETAS BV, De Limes 7, Oegstgeest, 2342DH, NETHERLANDS. |